Company news
Coiled Therapeutics PLC news in 2023
Coiled Therapeutics PLC's news releases, calls and decks from 2023, newest first.
Change of Auditor
November 24, 2023
Significant Mesodermal Killer Cell Milestone
November 6, 2023
Interim Results to 30 June 2023
September 27, 2023
Investor Presentation via Investor Meet Company
September 22, 2023
Expansion of Patent Portfolio
August 14, 2023
Development of New Novel siRNA Therapeutics
August 7, 2023
AGM Statement
June 29, 2023
RNA Medicine Shows In Vitro Anti-Cancer Efficacy
June 22, 2023
Antibody Program Results & Orphan Drug Indication
June 19, 2023
Anti-Cancer MDK mRNA - Positive in vitro Results
June 13, 2023
Restoration of Trading
June 7, 2023
Annual Report & Financial Statements - 31 Dec 2022
June 5, 2023
Suspension of Trading Pending 2022 Annual Report
May 2, 2023
Confirmation of No Exposure to Silicon Valley Bank
March 13, 2023
Creation of New Novel Family of mRNA Therapeutics
March 8, 2023
Formation of Scientific Advisory Board
March 6, 2023
Company Presentation
March 1, 2023
Randox Licence and Royalty Agreement
February 20, 2023
MDK Oncology Antibodies Demonstrate In-Vivo Safety
January 24, 2023
Appointment of Auditor
January 16, 2023